LYKALABS:NSE Lyka Labs Limited

INR 106.10 -1.45 -1.34821
Icon

Lyka Labs Limited (LYKALABS:NSE) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

INR 106.10

-1.45 (-1.35)%

INR 4.12B

0.07M

N/A

N/A

Icon

LYKALABS:NSE

Lyka Labs Limited (INR)
COMMON STOCK | NSE
INR 106.10
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

INR 4.12B

N/A

INR 106.10

Lyka Labs Limited (LYKALABS:NSE) Stock Forecast

N/A

Based on the Lyka Labs Limited stock forecast from 0 analysts, the average analyst target price for Lyka Labs Limited is not available over the next 12 months. Lyka Labs Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Lyka Labs Limited is Slightly Bearish, which is based on 4 positive signals and 7 negative signals. At the last closing, Lyka Labs Limited’s stock price was INR 106.10. Lyka Labs Limited’s stock price has changed by -3.59% over the past week, -12.75% over the past month and +4.02% over the last year.

No recent analyst target price found for Lyka Labs Limited
No recent average analyst rating found for Lyka Labs Limited

Company Overview Lyka Labs Limited

Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. The company manufactures and sells various formulations, including emollient, topical s...Read More

https://www.lykalabs.com

Spencer Building, Mumbai, India, 400036

296

March

INR

India

Adjusted Closing Price for Lyka Labs Limited (LYKALABS:NSE)

Loading...

Unadjusted Closing Price for Lyka Labs Limited (LYKALABS:NSE)

Loading...

Share Trading Volume for Lyka Labs Limited Shares

Loading...

Compare Performance of Lyka Labs Limited Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for LYKALABS:NSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Lyka Labs Limited (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
BIOCON:NSE
Biocon Limited +7.55 (+2.94%) INR317.69B 26.47 10.66

ETFs Containing LYKALABS

Symbol Name LYKALABS's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Lyka Labs Limited (LYKALABS:NSE) Stock

Stock Target Advisor's fundamental analysis for Lyka Labs Limited's stock is Slightly Bearish.

Unfortunately we do not have enough data on LYKALABS:NSE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on LYKALABS:NSE's stock to indicate what its average analyst target is.

LYKALABS:NSE stock's Price/Earning ratio is 23.63. Our analysis grades LYKALABS:NSE stock's Price / Earning ratio at B-. This means that LYKALABS:NSE stock's Price/Earning ratio is above 20% of the stocks in the Biotechnology sector in the NSE exchange. Based on this LYKALABS:NSE may be undervalued for its sector.

The last closing price of LYKALABS:NSE's stock was INR 106.10.

The most recent market capitalization for LYKALABS:NSE is INR 4.12B.

Unfortunately we do not have enough analyst data on LYKALABS:NSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Lyka Labs Limited's stock.

As per our most recent records Lyka Labs Limited has 296 Employees.

Lyka Labs Limited's registered address is Spencer Building, Mumbai, India, 400036. You can get more information about it from Lyka Labs Limited's website at https://www.lykalabs.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...